Russell John Tait

Title: Russell John Tait: Innovator in Pharmaceutical Composition

Introduction

Russell John Tait is a notable inventor based in Deepdene, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions. His innovative work has led to the creation of a unique pharmaceutical composition that addresses specific medical needs.

Latest Patents

Russell John Tait holds a patent for a pharmaceutical composition designed for topical administration. This composition includes, as the pharmaceutically active component, at least 5% by weight of a piperidinopyrimidine derivative or a pharmaceutically acceptable salt thereof. Additionally, it contains an acid to completely solubilize the active component and a solvent composition that includes at least two of water, a lower alcohol, and a co-solvent selected from aromatic and polyhydric alcohols. Notably, when the co-solvent includes propylene glycol, it is present in an amount of less than approximately 10% by weight. This innovative formulation has the potential to enhance the effectiveness of topical treatments.

Career Highlights

Russell John Tait is associated with Connetics Australia Pty Ltd., where he continues to contribute to advancements in pharmaceutical technology. His work is characterized by a commitment to improving patient outcomes through innovative solutions.

Collaborations

Throughout his career, Russell has collaborated with esteemed colleagues, including Tony Wai-Chiu So and Peter Paul Deo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the pharmaceutical field.

Conclusion

Russell John Tait's contributions to pharmaceutical compositions exemplify the impact of innovation in healthcare. His patent reflects a dedication to developing effective treatments that can significantly benefit patients.